Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Much of the total disease burden and cost of chronic obstructive pulmonary disease (COPD) is associated with acute exacerbations of COPD (AECOPD). Serum amyloid A (SAA) is a novel candidate exacerbation biomarker identified by proteomic screening. To assess SAA as a biomarker of AECOPD. Biomarkers w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2008-02, Vol.177 (3), p.269-278
Hauptverfasser:	Bozinovski, Steven, Hutchinson, Anastasia, Thompson, Michelle, MacGregor, Lochlan, Black, James, Giannakis, Eleni, Karlsson, Anne-Sophie, Silvestrini, Roger, Smallwood, David, Vlahos, Ross, Irving, Louis B, Anderson, Gary P
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Biomarkers - blood C-Reactive Protein - analysis Chronic obstructive pulmonary disease, asthma Cross-Sectional Studies Female Humans Intensive care medicine Longitudinal Studies Male Medical sciences Middle Aged Pneumology Proteomics Pulmonary Disease, Chronic Obstructive - blood Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - physiopathology Sensitivity and Specificity Serum Amyloid A Protein - metabolism Severity of Illness Index Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!